Journal of Clinical Apheresis
IF
1.63
Papers
1488
Papers 1606
1 page of 161 pages (1,606 results)
Newest
#1José Carlos Jaime-Pérez (Universidad Autónoma de Nuevo León)H-Index: 21
#2Ana L. Beltrán-López (Universidad Autónoma de Nuevo León)
Last. David Gómez-Almaguer (Universidad Autónoma de Nuevo León)H-Index: 27
view all 6 authors...
BACKGROUND Optimization of platelet (PLT) apheresis collection is a priority to satisfy the increasing demand of hemato-oncology patients. We assessed the performance of a plateletpheresis unit supporting hematology patients. STUDY DESIGN AND METHODS This descriptive retrospective study included 561 plateletpheresis collections from 2013 to 2018. For data analysis, descriptive statistics and receiver operating characteristic (ROC) curve were used. A 5-item satisfaction questionnaire was analyzed...
Source
#1Saurav Chopra (UIHC: University of Iowa Hospitals and Clinics)
#2Aayushi Garg (UIHC: University of Iowa Hospitals and Clinics)H-Index: 2
Last. John L Blau (UIHC: University of Iowa Hospitals and Clinics)H-Index: 7
view all 4 authors...
INTRODUCTION Therapeutic plasma exchange (TPE) is often impacted by difficulties in obtaining an adequate and safe vascular access. This study evaluated the rates, predictive factors, and clinical outcomes associated with central venous catheter (CVC) use during the inpatient TPE procedures. METHODS The Nationwide Readmissions Database, 2016 to 2017 was used to identify hospitalizations with TPE with and without CVC insertion. RESULTS During the study period, there were 35 429 hospitalizations w...
Source
#1Shraddha Patel Babariya (ARC: American Red Cross)
#2Angelica Vivero (Thomas Jefferson University Hospital)
Last. Julie Katz Karp (Thomas Jefferson University Hospital)H-Index: 8
view all 4 authors...
BACKGROUND The prevalence of obesity in the United States is estimated at 42.4% and expected to increase over the next decade. Therefore, understanding how to best perform certain medical procedures on severely obese (SO) patients is a necessity. This study presents results on the current methods of performing therapeutic plasma exchange (TPE) on SO patients. This paper aims to contribute to the existing literature by providing new insights into calculating plasma volume (PV) for TPE in SO patie...
Source
#1Eric Salazar (Houston Methodist Hospital)H-Index: 14
#2Faaria Gowani (UTHSC: University of Tennessee Health Science Center)
Last. Salvador Garcia (Houston Methodist Hospital)H-Index: 1
view all 17 authors...
BACKGROUND Apheresis procedures require adequate vascular access to achieve adequate inlet flow rates. Central dialysis-type catheters are often used in apheresis, despite their multiple risks. Peripheral venous access is a safe and effective option for many patients. AIM We previously demonstrated that ultrasound guidance reduces central venous catheter use in apheresis patients; however, no validated criteria for preprocedural evaluation of peripheral veins exist. Here, we hypothesized that ul...
Source
#1Hamza Naciri Bennani (UGA: University of Grenoble)H-Index: 3
#2Raphael Marlu (UGA: University of Grenoble)H-Index: 6
Last. Johan Noble (UGA: University of Grenoble)H-Index: 7
view all 10 authors...
Background null Double-filtration plasmapheresis (DFPP), a selective therapeutic apheresis, can deplete pathogenic antibodies/substances, but also important coagulation factors. null Aim null To determine if the use of a separator filter with different characteristics (CascadefloEC-50 W) as compared to the reference filter (PlasmafloOP-08 W) is as efficient in terms of immunoglobulin loss, but can reduce coagulation factor losses and have similar tolerability. null Patients/methods null This is ...
Source
#1Carlos Esteban Builes-Montaño (UdeA: University of Antioquia)H-Index: 3
#2Luis A Rodriguez-Arrieta (UdeA: University of Antioquia)
Last. Clara María Arango-Toro (UdeA: University of Antioquia)
view all 7 authors...
BACKGROUND AND AIMS Thyroid storm and severe thyrotoxicosis remain among the most frequent endocrine emergencies, and first-line hyperthyroidism treatment is not always an option. Since the first report in 1970, plasmapheresis is a second-line treatment for severe or otherwise untreatable thyrotoxicosis when rapid euthyroidism is desired. METHODS We present a retrospective study of the experience in treating thyrotoxicosis with plasmapheresis between 2012 and 2020 in two specialized centers in C...
Source
#1Haruhiko Ogawa (Kanazawa University)H-Index: 5
#2Yasushi KakuchiH-Index: 7
Last. Hidesaku Asakura (Kanazawa University)H-Index: 33
view all 3 authors...
Source
#1Nicole D. Zantek (UMN: University of Minnesota)H-Index: 18
#2Ryan J. Martinez (UMN: University of Minnesota)H-Index: 11
Last. Surbhi Shah (UMN: University of Minnesota)H-Index: 4
view all 5 authors...
INTRODUCTION Indications for apheresis procedures are expanding; however, the evidence for many is low quality. A better understanding of apheresis patterns in the United States is needed to better plan prospective research studies. METHODS Data from January 1, 2013, to September 30, 2015, were analyzed from the IBM MarketScan Research Databases of de-identified health insurance claims data of several million enrollees at all levels of care from large employers and health plans across the United...
Source
#1Melissa R. George (Penn State Milton S. Hershey Medical Center)H-Index: 6
#2Diane M. Strine (Penn State Milton S. Hershey Medical Center)
Last. Sandra M. Niyibizi (Penn State Milton S. Hershey Medical Center)
view all 4 authors...
Source
#1Hunter Sheckley (MU: University of Missouri)
#2Kunal Malhotra (MU: University of Missouri)H-Index: 3
Last. Raghav Govindarajan (MU: University of Missouri)H-Index: 9
view all 5 authors...
Background null Despite the availability of several immunomodulatory therapies, about 20% of myasthenia gravis (MG) patients remain refractory to conventional treatments. There is limited evidence to support the use of maintenance therapeutic plasma exchange (TPE) therapy for refractory generalized MG. null Methods null Retrospective chart review of 14 patients with refractory generalized MG treated for 12 months with maintenance TPE therapy. Outcome measures were myasthenia gravis composite (MG...
Source
12345678910
Top fields of study
Surgery
Immunology
Apheresis
Plasmapheresis
Diabetes mellitus
Medicine
Gastroenterology